Blood Draw

COVID-19

Patients Providers

clipboard

We offer 1800+ tests in clinical, molecular and anatomic pathology.

FIND A TEST
Doctor

With over 18 subspecialties and 60+ experts, we can help with even the most difficult cases. 

GET STARTED
Blood Draw

Visit one of our 21 specimen collection sites.

SEARCH NOW

NEWS & EVENTS

June 10, 2022

New Patient Service Center - Convenient for Ann Arbor/Ypsilanti Patients

In partnership with Packard Health, Michigan Medicine Laboratories, has opened a new laboratory patient service center for specimen collection at Packard Health Main (2650 Carpenter Road, Ann Arbor, MI 48108). The facility houses phlebotomists skilled in caring for patients of all ages and appointments are not needed.

March 18, 2022

Join us at USCAP 2022!

Michigan Medicine Laboratories will be exhibiting  at USCAP this month. The 11th annual meeting runs from March 19-24, 2022 in Los Angeles, CA. Be sure to stop by booth 633 and grab a go blue football!

 

February 2, 2022

West Ann Arbor Blood Draw - Closing Early on 2/3 and 2/3

The West Ann Arbor Blood Draw center located at 380 Parkland Plaza, Suite 130, Ann Arbor, MI 48103 will be closing early at 5:00pm on Wednesday, February 2nd and Thursday, February 3rd. For more information about the blood draw site, please visit West Ann Arbor Health Center | MLabs (umich.edu)

SEE ALL NEWS

Featured Test

 

NGS Solid Tumor Panel


Molecular testing of solid tumor neoplasms - particularly advanced-stage cancer. This DNA and RNA based, NGS test targets 50 actionable genes (35 mutations, 19 amplifications, 21 - fusions). Requires <1mm2 of tissue (as little as 100 tumor cells) and a low 3% QNS rate. 

 

LEARN MORE

Patient Older Woman Gown

Featured Test

 

PIK3CA Mutation: 

NEW TREATMENT OPTION FOR METASTATIC BREAST CANCER

MLabs offers NGS Solid Tumor Panel and Single gene test to detect PIK3CA for FDA approved therapy alpelisib (Piqray®).


LEARN MORE
 

Older Woman and Girl Hugging Beach

Featured Test

 

Myeloid NGS Panel

This test is intended for the molecular evaluation of myeloid neoplasms including myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), myelodysplastic/myeloproliferative neoplasms, acute myeloid leukemias (AML), mastocytosis and myeloid neoplasms with eosinophilia and gene rearrangement.


LEARN MORE

Senior woman thinking

Featured Test

 

FGFR Mutation/Translocation


Erdafitinib (Balversa™) is an FGFR-inhibitor that is FDA-approved for the treatment of metastatic urothelial cancers harboring susceptible mutations or translocations involving FGFR2 or FGFR3. 
 

LEARN MORE

NCRC Staff

Featured Test

 

NR4A3 (9q22-9q31) Rearrangement (FISH)

NR4A3 encodes an orphan nuclear receptor. Rearrangements of NR4A3 occur in more than 80% of extraskeletal myxoid chondrosarcoma (EMC) as well as in salivary acinic cell carcinoma (AciCC), driving tumorigenesis. 


LEARN MORE

Dr Brown

Featured Test

 

TFE3 Rearrangement (FISH)

 Detecting rearrangements involving the TFE3 gene region (Xp11.2) via fluorescence in situ hybridization (FISH) to qualitatively assess for the presence of TFE3 translocations that are associated with certain subtypes of renal cell carcinoma. Testing for TFE3 gene rearrangement may aid in the diagnosis and classification of renal tumors.


LEARN MORE

NCRC Staff